Original language | English |
---|---|
Pages (from-to) | 807-808 |
Number of pages | 2 |
Journal | Infection Control and Hospital Epidemiology |
Volume | 30 |
Issue number | 8 |
DOIs | |
Publication status | Published (in print/issue) - Aug 2009 |
Bibliographical note
Export Date: 15 September 2018CODEN: ICEPE
Correspondence Address: McElnay, J. C.; Department of Pharmacy Practice, Clinical and Practice Research Group, Queen's University Belfast, Belfast BT9 7BL, United Kingdom; email: [email protected]
Chemicals/CAS: amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7; ciprofloxacin, 85721-33-1; metronidazole, 39322-38-8, 443-48-1; Anti-Bacterial Agents; Ciprofloxacin, 85721-33-1; Penicillanic Acid, 87-53-6; Piperacillin, 61477-96-1; piperacillin-tazobactam combination product, 157044-21-8
Tradenames: tazocin
References: Kollef, M.H., Fraser, V.J., Antibiotic resistance in the intensive care unit (2001) Ann Intern Med, 134, pp. 298-314; Carlet, J., Ben Ali, A., Chalfine, A., Epidemiology and control of antibiotic resistance in the intensive care unit (2004) Curr Opin Infect Dis, 17, pp. 309-316; Mcgowan Jr., J.E., Antimicrobial resistance in hospital organisms and its relation to antibiotic use (1983) Rev Infect Dis, 5, pp. 1033-1048; Muller, A.A., Mauny, F., Bertin, M., Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital (2003) Clin Infect Dis, 36, pp. 971-978; Monnet, D.L., Mackenzie, F.M., Lopez-Lozano, J.M., Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000 (2004) Emerg Infect Dis, 10, pp. 1432-1441; Aldeyab, M.A., Monnet, D.L., López-Lozano, J.M., Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: A time-series analysis (2008) J Antimicrob Chemother, 62, pp. 593-600; Aldeyab, M.A., Hughes, C.M., Kearney, M.P., Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit (2008) Int J Antimicrob Agents, 32, pp. 499-504; EuroQol: A new facility for the measurement of health related quality of life (1990) Health Policy, 16, pp. 199-208. , EuroQol Group; Dolan, P., Modeling valuations for EuroQol health states (1997) Med Care, 35, pp. 1095-1108
Keywords
- amoxicillin
- antibiotic agent
- ciprofloxacin
- metronidazole
- piperacillin plus tazobactam
- add on therapy
- anaerobic infection
- antibiotic resistance
- antibiotic therapy
- APACHE
- comparative study
- health care
- health care policy
- health status
- hospital discharge
- human
- intensive care unit
- letter
- methicillin resistant Staphylococcus aureus
- methicillin resistant Staphylococcus aureus infection
- nonhuman
- quality of life
- visual analog scale
- Anti-Bacterial Agents
- Ciprofloxacin
- Drug Resistance, Bacterial
- Health Status
- Humans
- Intensive Care Units
- Outcome Assessment (Health Care)
- Patient Discharge
- Penicillanic Acid
- Piperacillin
- Quality of Life
- Questionnaires